You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human epidermal growth factor receptor 2 low

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Breast Cancer Invasive Trial (pyrotinib)

Not yet recruiting
  • Breast Cancer Invasive
  • (no location specified)
Jun 18, 2023

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

Recruiting
  • Breast Cancer
    • Arkhangelsk, Russian Federation
    • +41 more
    Jun 28, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Breast Cancer Trial (Tucatinib, Doxil)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Feb 17, 2023

    Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

    Not yet recruiting
    • Recurrent Glioblastoma
    • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
    • (no location specified)
    Apr 4, 2023

    Older Women With ER Positive, HER2 Negative Early Breast Cancer

    Enrolling by invitation
    • Breast Cancer Female
    • Translational study
    • Sutton, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Feb 8, 2023

    Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

    Recruiting
    • Brain Metastases
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 8, 2022

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

    Recruiting
    • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 21, 2023

    Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

    Completed
    Has Results
    • Breast Neoplasms
    • +3 more
    • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 12, 2022

    NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Mar 24, 2023

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • AND019 PO QD
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 19, 2022

    HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

    Recruiting
    • HER2-positive Breast Cancer
    • HER-2 pulsed DC1
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 6, 2022

    EGFR Mutation-Related Tumors Trial (NX-019)

    Not yet recruiting
    • EGFR Mutation-Related Tumors
    • (no location specified)
    Aug 22, 2022

    Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

    Not yet recruiting
    • Breast Cancer
    • +8 more
    • (no location specified)
    Feb 9, 2023

    Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant (SAR439859)
    • Chuo-Ku, Japan
    • +2 more
    Nov 16, 2022

    HER-2 Expression in Pancreatic Duct Adenocarcinoma

    Completed
    • Pancreatic Adenocarcinoma
    • immunohistochemical approach
    • (no location specified)
    Sep 20, 2023